Avenue Therapeutics, Inc. (ATXI)

CIK 1644963 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avenue Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 202610-Q0001437749-26-026372
May 8, 202610-Q0001437749-26-015759
Mar 30, 202610-K0001437749-26-010359
Feb 23, 20268-K0001104659-26-018582
Feb 17, 2026SCHEDULE 13G/A0001193125-26-055056
Jan 6, 202640001429260-26-000004
Jan 6, 2026SCHEDULE 13D/A0001104659-26-001305
Dec 31, 20258-K0001104659-25-125420
Dec 16, 2025EFFECT9999999995-25-003776
Dec 15, 2025RW0001104659-25-121121
Dec 15, 2025POS AM0001104659-25-121247
Dec 5, 2025DEF 14A0001437749-25-037023
Nov 18, 20258-K0001437749-25-035624
Nov 13, 202510-Q0001437749-25-034821
Aug 14, 202510-Q0001437749-25-026935
Jul 18, 202525-NSE0001354457-25-000696
May 15, 202510-Q0001437749-25-017180
Apr 30, 20258-K0001104659-25-042570
Apr 2, 202540001415889-25-009621
Apr 2, 2025SCHEDULE 13D/A0001104659-25-031241
Mar 31, 202510-K0001437749-25-010196
Mar 17, 20258-K0001104659-25-024505
Mar 7, 20258-K0001437749-25-006685
Feb 14, 2025SCHEDULE 13G0000950170-25-020873
Feb 14, 2025SCHEDULE 13G/A0001172661-25-001238